Limits...
Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.

Denardo SJ, Gong Y, Cooper-DeHoff RM, Farsang C, Keltai M, Szirmai L, Messerli FH, Bavry AA, Handberg EM, Mancia G, Pepine CJ - PLoS ONE (2015)

Bottom Line: Clinicaltrials.gov; NCT00133692.

View Article: PubMed Central - PubMed

Affiliation: Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, Florida, United States of America.

ABSTRACT

Trial registration: Clinicaltrials.gov; NCT00133692.

No MeSH data available.


Consort diagram showing selection of INVEST patients for the ambulatory monitoring substudy analysis.The subgroup consisted of 141 patients undergoing 24-hour ambulatory monitoring at baseline and after 1 year of treatment. Patients were excluded if their blood pressure and heart rate recordings did not meet the criteria for inclusion (adequate technical quality ≥85% of the 24-hour recording period, <3 consecutive hours without valid measurements, and <4 non-consecutive hours without valid measurements).
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4383326&req=5

pone.0122726.g001: Consort diagram showing selection of INVEST patients for the ambulatory monitoring substudy analysis.The subgroup consisted of 141 patients undergoing 24-hour ambulatory monitoring at baseline and after 1 year of treatment. Patients were excluded if their blood pressure and heart rate recordings did not meet the criteria for inclusion (adequate technical quality ≥85% of the 24-hour recording period, <3 consecutive hours without valid measurements, and <4 non-consecutive hours without valid measurements).

Mentions: The 141 patients with ambulatory monitoring measurements were recruited from 13 sites, representing a 68% participation rate for this substudy. Technically valid BP and HR recordings were available in 117 patients both at baseline and after 1 year of treatment (Fig 1). Baseline clinical characteristics were similar for these 117 patients comparing treatment strategies (Table 1). Additionally, baseline office SBP, DBP, and HR were similar for these patients and were also similar to the remaining 22,459 INVEST patients (Fig 2).


Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.

Denardo SJ, Gong Y, Cooper-DeHoff RM, Farsang C, Keltai M, Szirmai L, Messerli FH, Bavry AA, Handberg EM, Mancia G, Pepine CJ - PLoS ONE (2015)

Consort diagram showing selection of INVEST patients for the ambulatory monitoring substudy analysis.The subgroup consisted of 141 patients undergoing 24-hour ambulatory monitoring at baseline and after 1 year of treatment. Patients were excluded if their blood pressure and heart rate recordings did not meet the criteria for inclusion (adequate technical quality ≥85% of the 24-hour recording period, <3 consecutive hours without valid measurements, and <4 non-consecutive hours without valid measurements).
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4383326&req=5

pone.0122726.g001: Consort diagram showing selection of INVEST patients for the ambulatory monitoring substudy analysis.The subgroup consisted of 141 patients undergoing 24-hour ambulatory monitoring at baseline and after 1 year of treatment. Patients were excluded if their blood pressure and heart rate recordings did not meet the criteria for inclusion (adequate technical quality ≥85% of the 24-hour recording period, <3 consecutive hours without valid measurements, and <4 non-consecutive hours without valid measurements).
Mentions: The 141 patients with ambulatory monitoring measurements were recruited from 13 sites, representing a 68% participation rate for this substudy. Technically valid BP and HR recordings were available in 117 patients both at baseline and after 1 year of treatment (Fig 1). Baseline clinical characteristics were similar for these 117 patients comparing treatment strategies (Table 1). Additionally, baseline office SBP, DBP, and HR were similar for these patients and were also similar to the remaining 22,459 INVEST patients (Fig 2).

Bottom Line: Clinicaltrials.gov; NCT00133692.

View Article: PubMed Central - PubMed

Affiliation: Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, Florida, United States of America.

ABSTRACT

Trial registration: Clinicaltrials.gov; NCT00133692.

No MeSH data available.